Edition:
United Kingdom

Marrone Bio Innovations Inc (MBII.OQ)

MBII.OQ on NASDAQ Stock Exchange Capital Market

0.95USD
15 Dec 2017
Change (% chg)

$0.02 (+2.07%)
Prev Close
$0.93
Open
$0.94
Day's High
$0.95
Day's Low
$0.90
Volume
14,144
Avg. Vol
23,318
52-wk High
$2.45
52-wk Low
$0.85

Latest Key Developments (Source: Significant Developments)

Marrone Bio Innovations qtrly ‍basic, diluted net loss per common share $0.27​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Marrone Bio Innovations Inc ::Marrone Bio Innovations, Inc reports third quarter 2017 financial results.Q3 revenue rose 16 percent to $4.2 million.Marrone Bio Innovations Inc - qtrly ‍basic and diluted net loss per common share $0.27​.  Full Article

Marrone Bio Innovations receives EPA approval for novel biofungicide
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Marrone Bio Innovations Inc ::Marrone Bio Innovations receives EPA approval for novel biofungicide.Marrone Bio Innovations Inc - ‍received approval from U.S. Environmental Protection Agency on its newest biological fungicide, Stargus​.Marrone Bio Innovations Inc - ‍MBI expects first sales when state registrations are granted​.Marrone Bio Innovations - biofungicide has been submitted to Canada, Mexico for approval & dossier is being prepared for Europe.  Full Article

Marrone Bio signs exclusive agreement with Kenya Biologics
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Marrone Bio Innovations Inc :Marrone Bio Innovations signs exclusive distribution agreement with Kenya Biologics Ltd. For Kenya and Tanzania.Marrone Bio Innovations Inc - ‍ signed exclusive distribution agreement with Kenya Biologics Ltd to bring MBI's biopesticides to Kenya and Tanzania​.  Full Article

Marrone Bio files for mixed shelf of up to $50 million
Friday, 9 Dec 2016 

Marrone Bio Innovations Inc :Marrone Bio Innovations - files for mixed shelf of up to $50 million.  Full Article

Marrone Bio says Mexico regulatory authorities approve GRANDEVO, VENERATE for sale
Tuesday, 26 Jul 2016 

Marrone Bio Innovations Inc :Mexico regulatory authorities have approved for sale both of company's bioinsecticides, grandevo and venerate.  Full Article

Marrone Bio says lenders waive $15 mln minimum cash balance requirement
Thursday, 2 Jun 2016 

Marrone Bio Innovations Inc : On May 31, entered into an amendment to its senior secured promissory notes, dated August 20, 2015 - sec filing .Investors agreed to delete from notes provisions that had required company to maintain a $15 million minimum cash balance.  Full Article

Marrone Bio says agreed to settle class action litigation
Thursday, 26 May 2016 

Marrone Bio Innovations Inc : Agreement provides for a settlement payment to class of $12 million . Payment will be paid by insurance carriers .Marrone Bio Innovations announces agreement to settle class action litigation.  Full Article

Marrone Bio Innovations reports Q1 net loss $9.3 million
Thursday, 12 May 2016 

Marrone Bio Innovations Inc : Says net loss for Q1 of 2016 was $9.3 million, compared to a loss of $11.9 million in Q1 of 2015 .Q1 revenue $2.7 million versus $2.1 million.  Full Article